Navigation Links
JAMA Article Provides False Support for CDC's Do-Nothing Position on MRSA
Date:3/11/2008

NEW YORK, March 11 /PRNewswire-USNewswire/ -- A new study in the Journal of the American Medical Association (JAMA) purports to show that screening for MRSA (methicillin-resistant Staphylococus aureus), a simple skin or nasal swab, is not effective in reducing MRSA hospital infections ("Universal Screening for Methicillin-Resistant Staphylococcus aureus at Hospital Admission and Nosocomial Infection in Surgical Patients," JAMA vol. 299, no. 10, March 12, 2008).

The findings of the authors will be seized upon by the Centers for Disease Control and Prevention (CDC) and advocates of the do-nothing status quo. But the study is seriously flawed -- rendering its findings meaningless.

Researchers used a 'rapid test,' but many patients were not tested until they had already been in the hospital for twelve hours. Furthermore, the results of the MRSA tests were not acted upon for another 221/2 hours on average. Most patients had completed more than half of their hospital stay before their results were known. Therefore, the precautions they needed -- isolation, proper antibiotics, chlorhexidine baths -- were taken late or not at all.

Unbelievably, almost a third of surgical patients (31%) who tested positive didn't get their test results until after their surgery. Therefore they too didn't receive any of the precautions they needed. Some people carry MRSA germs in their noses or on their skin without realizing it. The bacteria do not cause infection unless they get inside the body -- usually via a catheter, a ventilator, or an incision or other open wound.

No weekly MRSA testing was conducted, which is de rigour when conducting universal screening to prevent patients colonized with MRSA from passing it on to other patients in the hospital.

A previous study by the same lead author at the same location, The University of Geneva Hospital, found that universal screening on admission with preemptive contact precautions (the way it's supposed to be done) decreased MRSA infections in the medical intensive care unit.

The study released today, says Betsy McCaughey, Chairman of the Committee to Reduce Infection Deaths, "doesn't prove that MRSA screening is ineffective. The study omits the precautions that are supposed to follow a MRSA positive test result. It's like testing a recipe, but omitting half the ingredients or test-driving a car without the tires."

Today's JAMA article provides false support for the CDC's persistent do-nothing position on the dire problem of M.R.S.A. The CDC's lax guidelines continue to give hospitals an excuse to do too little.


'/>"/>
SOURCE Committee to Reduce Infection Deaths
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Novel 3-D cell culture model shows selective tumour uptake of nanoparticles
2. GlaxoSmithKline Responds to JAMA Articles
3. Developing a modular, nanoparticle drug delivery system
4. Voxant, the New Media Network, Distributes More Than 43,000 Health News Videos, Articles and Images
5. Dynamic Files Articles of Merger; Notifies Nasdaq of Merger with GeoPharma
6. The Journal of the American Medical Association (JAMA) Article Reveals Scope of MRSA Infections
7. Mayo Clinic Proceedings article explores possible link between obesity and viral infections
8. American College of Surgeons Comments on JAMA Article on Surgeon Shortage
9. CQRC Statement on the NY Times Article on Medicares Home Oxygen Benefit
10. Statement from American Association for Homecare on New York Times Article about Home Oxygen Therapy
11. WSJ Article Prompts AHF to Renew Call for CDC to Release Stark New HIV Data
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/29/2017)... Mt. Horeb, WI (PRWEB) , ... March 29, 2017 , ... ... her patients on early orthodontic treatment and accepting new pediatric patients, with or without ... can help young patients have a better orthodontic outcome and experience. When patients receive ...
(Date:3/29/2017)... ... March 29, 2017 , ... Curio Wellness , a ... the finalization of the company’s executive management team with prominent executives from both inside ... Curio Wellness’ Chief Operating Officer, Ted Dumbauld , who has more than twenty ...
(Date:3/29/2017)... ... March 29, 2017 , ... Immunotherapy has emerged as one of ... and is touted to be the next revolution in our fight against this complex ... the form of immune checkpoint inhibitors such as PD-1 and PD-L1 inhibitors. , While ...
(Date:3/29/2017)... ... March 29, 2017 , ... The Wharton School of the University of ... W’81, have made a $10 million gift to establish the Ken Moelis and ... a pathway to a Wharton MBA for highly-qualified Penn undergraduates whose academic and career ...
(Date:3/28/2017)... , ... March 28, 2017 , ... Tuesday, March 28, ... American public to take the Diabetes Risk Test to find out if they are ... Angeles World Airports will light up the evening sky by programming the LAX pylons ...
Breaking Medicine News(10 mins):
(Date:3/29/2017)... According to a new market research report "Medical Radiation Detection, Monitoring & ... Products (Personal Dosimeters, OSL, Badges), Safety (Apron, Shields, Face Mask, Gloves), End ... to reach USD 1,215.4 Million by 2021 from USD 887.0 Million in ... Continue Reading ... ...
(Date:3/29/2017)... , March 29, 2017  Maxor National Pharmacy ... announced that it has named Leah Bailey ... all divisions of the company. With more ... the previous 8 years focused on health care, Bailey ... her tenure at Prime, Bailey advised the PBM, Specialty, ...
(Date:3/29/2017)... 2017  The Pharmaceutical Care Management Association (PCMA) today ... on patient out-of-pocket spending: ... (CMS), the average amount spent out-of-pocket for drugs continues ... in 2016, down from 23% in 2006. ... a coverage problem. Health plans don,t have unlimited funds ...
Breaking Medicine Technology: